Zai Lab (shanghai) Co., Ltd.

This study tests an experimental drug called ZL-1310, alone or with other cancer medicines, in people with small cell lung cancer. The goal is to see if it is safe and can shrink tumors or slow the disease. About 339 adults with advanced or spreading small cell lung cancer will t…

This study tests a new drug, ZL-1310, designed to target and destroy cancer cells in people with small cell lung cancer that has come back after initial treatment. About 480 adults will be randomly assigned to receive either ZL-1310 or one of several standard treatments. The goal…

This study tests an experimental drug called ZL-1310 in about 112 adults with advanced neuroendocrine carcinomas that have worsened after standard chemotherapy. The goal is to see if the drug can shrink tumors and to check for side effects. Participants will receive the drug and …

This phase 3 trial tests whether the drug ZL-1109 can reduce eye bulging and other symptoms in people with moderate to severe thyroid eye disease. About 99 Chinese adults with active disease will receive either the drug or a placebo. The study aims to see if the treatment can hel…

This early-stage study is testing a new experimental drug called ZL-6201 in adults with advanced sarcoma and other solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and understand how the body processes the drug, while also lookin…

This early-stage study tests whether a new medicine called ZL-1503 is safe for people with moderate to severe atopic dermatitis (eczema). About 84 healthy volunteers and eczema patients will receive either the drug or a placebo. Researchers will monitor for side effects and how t…